Skip to Main Content

Paper Details

Fibrolamellar carcinoma transcriptomic-based treatment prediction: complete response after nivolumab and ipilimumab.
J Immunother Cancer
4
2022
FLC, Fibrolamellar carcinoma, anti-CTLA4, anti-PD-1, cancer of the liver, children, hepatocellular carcinoma, patient
Author NameAffiliation
Kenneth AldapeCenter for Cancer Research
Kenneth AldapeCenter for Cancer Research
Eytan RuppinCenter for Cancer Research
  • 1 - 3

Datasets

Release 1.2